1.58
-0.01(-0.63%)
Currency In USD
| Previous Close | 1.59 |
| Open | 1.64 |
| Day High | 1.64 |
| Day Low | 1.53 |
| 52-Week High | 13.2 |
| 52-Week Low | 1.45 |
| Volume | 224,929 |
| Average Volume | 251,185 |
| Market Cap | 5.19M |
| PE | -0.12 |
| EPS | -12.69 |
| Moving Average 50 Days | 1.62 |
| Moving Average 200 Days | 2.83 |
| Change | -0.01 |
If you invested $1000 in Bionano Genomics, Inc. (BNGO) since IPO date, it would be worth $25.69 as of January 14, 2026 at a share price of $1.58. Whereas If you bought $1000 worth of Bionano Genomics, Inc. (BNGO) shares 5 years ago, it would be worth $0.38 as of January 14, 2026 at a share price of $1.58.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results
GlobeNewswire Inc.
Jan 12, 2026 1:00 PM GMT
SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. “2025 was a
Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025
GlobeNewswire Inc.
Dec 11, 2025 1:00 PM GMT
SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key presentations at the conference highlighted how
Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies
GlobeNewswire Inc.
Dec 03, 2025 1:00 PM GMT
SAN DIEGO, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), announced today t